Are you getting the best rate from your broker?
Compare your broker's rates now to find out if you can save money

Choose your broker below
Welcome to MutualFunds.com. Please help us personalize your experience.

Select the one that best describes you
Mutualfunds logo

AHSCX Alger Health Sciences C

  • Fund
  • AHSCX
  • Price as of: Nov 17, 2017
  • $20.23
  • - $0.04
  • - 0.20%
  • Category
  • Health & Biotech Equities

AHSCX - Profile

Vitals

  • YTD Return 35.7%
  • 3 Yr Annualized Return 11.2%
  • 5 Yr Annualized Return 15.8%
  • Net Assets $158 M
  • Holdings in Top 10 30.7%

52 WEEK LOW AND HIGH

$20.23
$13.20
$20.56

Expenses

OPERATING RELATED FEES

  • Expense Ratio 2.18%

SALES FEES

  • Front Load N/A
  • Deferred Load 1.00%

BROKERAGE FEES

  • Turnover 93.49%

TRADING FEES

  • Max Redemption Fee 2.00%

Min Investment

STANDARD (TAXABLE)

$1,000

IRA

$500

Investment Themes

CATEGORY

Health & Biotech Equities
  • Fund Type Open End Mutual Fund
  • Investment Style Health

Distributions

  • YTD Total Return 35.7%
  • 3 Yr Annualized Total Return 11.2%
  • 5 Yr Annualized Total Return 15.8%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio -1.65%
DIVIDENDS
  • Dividend Yield N/A
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name Alger Health Sciences Fund
  • Fund Family Name Alger
  • Inception Date May 01, 2002
  • Shares Outstanding N/A
  • Share Class C
  • Currency USD
  • Domiciled Country United States
  • Manager Teresa McRoberts

Fund Description

The fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of companies of any market capitalization that are engaged in the health sciences sector. It can invest in foreign securities.

AHSCX - Performance

Return Ranking - Trailing

Period AHSCX Return Category Return Low Category Return High Rank in Category (%) Quintile
YTD 35.7% -14.9% 36.8% 8.04% 1
1 Yr 36.9% -14.8% 43.9% 8.11% 1
3 Yr 11.2% * -7.5% 18.5% 18.52% 1
5 Yr 15.8% * 9.3% 22.0% 66.99% 4
10 Yr 9.7% * 6.1% 17.5% 70.87% 4

* Annualized


Return Ranking - Calendar

Period AHSCX Return Category Return Low Category Return High Rank in Category (%) Quintile
2016 -4.1% -29.8% 2.6% 12.73% 1
2015 -16.6% -20.4% 14.5% 96.36% 5
2014 -5.8% -5.8% 33.7% 98.18% 5
2013 10.9% -2.6% 65.2% 91.74% 5
2012 -2.6% -5.3% 36.5% 93.20% 5

Total Return Ranking - Trailing

Period AHSCX Return Category Return Low Category Return High Rank in Category (%) Quintile
YTD 35.7% -14.9% 36.8% 8.11% 1
1 Yr 35.9% -18.3% 43.9% 6.36% 1
3 Yr 11.2% * -14.2% 18.5% 14.81% 1
5 Yr 15.8% * 9.1% 22.0% 65.05% 4
10 Yr 9.7% * 6.1% 17.2% 68.93% 4

* Annualized


Total Return Ranking - Calendar

Period AHSCX Return Category Return Low Category Return High Rank in Category (%) Quintile
2016 -4.1% -25.1% 6.3% 15.60% 1
2015 -16.6% -16.6% 39.1% 99.08% 5
2014 -5.8% -5.8% 100.0% 99.08% 5
2013 10.9% -5.1% 398.7% 97.22% 5
2012 -2.6% -2.6% 475.8% 99.00% 5

NAV & Total Return History

AHSCX - Holdings

Filings data as of: Jun 30, 2017

Concentration Analysis

AHSCX Category Low Category High AHSCX % Rank Quintile
Net Assets 158 M 18.6 M 47 B 39.29% 5
Number of Holdings 95 31 361 16.96% 3
Net Assets in Top 10 44.1 M 11 M 20.2 B 40.18% 5
Weighting of Top 10 30.7% 19.8% 71.2% 41.07% 5

Top 10 Holdings

  1. Bristol-Myers Squibb Company 2.71%
  2. UnitedHealth Group Inc 4.32%
  3. Biomarin Pharmaceutical Inc 2.62%
  4. Abiomed Inc 2.69%
  5. Incyte Corp 3.33%
  6. Tolero Cdr/Rec 4.15%
  7. Vertex Pharmaceuticals Inc 3.50%
  8. Emmaus Life Sciences 2.59%
  9. Prosetta Biosciences Inc Series D Pfd 2.30%
  10. Johnson & Johnson 2.44%

Asset Allocation

Weighting Category Low Category High AHSCX % Rank Quintile
Stocks
91.83% 91.83% 99.98% 44.64% 5
Other
5.15% -5.64% 5.15% 0.89% 1
Preferred Stocks
2.60% 0.00% 4.16% 3.57% 1
Cash
0.43% -0.04% 5.66% 32.14% 4
Convertible Bonds
0.00% 0.00% 0.46% 2.68% 5
Bonds
0.00% 0.00% 4.69% 7.14% 5

Stock Sector Breakdown

Weighting Category Low Category High AHSCX % Rank Quintile
Healthcare
87.40% 11.15% 99.98% 44.64% 5
Technology
1.68% 0.00% 65.49% 18.75% 3
Consumer Defense
0.11% 0.00% 1.65% 13.39% 2
Financial Services
0.05% 0.00% 2.90% 4.46% 1
Utilities
0.00% 0.00% 0.95% 1.79% 5
Real Estate
0.00% 0.00% 1.52% 1.79% 5
Industrials
0.00% 0.00% 8.26% 8.04% 5
Energy
0.00% 0.00% 0.09% 1.79% 5
Communication Services
0.00% 0.00% 0.00% 0.89% 5
Consumer Cyclical
0.00% 0.00% 7.41% 7.14% 5
Basic Materials
0.00% 0.00% 2.25% 6.25% 5

Stock Geographic Breakdown

Weighting Category Low Category High AHSCX % Rank Quintile
US
87.80% 60.72% 99.98% 20.54% 2
Non US
4.03% 0.00% 34.72% 31.25% 4

AHSCX - Expenses

Operational Fees

AHSCX Fees (% of AUM) Category Low Category High Rank in Category (%) Quintile
Expense Ratio 2.18% 0.10% 4.31% 8.93% 5
Management Fee 0.81% 0.09% 1.25% 7.14% 3
12b-1 Fee 1.00% 0.00% 1.00% 1.27% 5
Administrative Fee 0.03% 0.01% 0.40% 18.46% 1

Sales Fees

AHSCX Fees (% of AUM) Category Low Category High AHSCX Rank Quintile
Front Load N/A 2.50% 5.75% N/A N/A
Deferred Load 1.00% 1.00% 5.00% 12.50% 3

Trading Fees

AHSCX Fees (% of AUM) Category Low Category High AHSCX Rank Quintile
Max Redemption Fee 2.00% 0.75% 2.00% 2.27% 5

Turnover Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

AHSCX Fees (% of AUM) Category Low Category High AHSCX Rank Quintile
Turnover 93.49% 0.00% 699.00% 5.36% 5

AHSCX - Distributions

Dividend Yield Analysis

AHSCX Category Low Category High AHSCX % Rank Quintile
Dividend Yield N/A 0.01% 0.94% N/A N/A

Dividend Distribution Analysis

AHSCX Category Low Category High Category Mode
Dividend Distribution Frequency Annually Annually Quarterly Annually

Dividend Payout History


Net Income Ratio Analysis

AHSCX Category Low Category High AHSCX % Rank Quintile
Net Income Ratio -1.65% -2.22% 1.46% 71.43% 5

Capital Gain Distribution Analysis

AHSCX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Semi-Annually Annually

AHSCX - Managers

Teresa McRoberts

Manager

Start Date

Feb 12, 2015

Tenure

2.63

Tenure Rank

27.2%

Teresa McRoberts is Senior Vice President, Senior Analyst, and Portfolio Manager. She first joined Alger in 1994. Before rejoining Alger in 2015, Teresa was the portfolio manager at Bienville Health Science Partners, a company she founded. Her previous experience includes health care portfolio manager roles at Galleon Group, Carlyle Blue Wave Partners, and Tribeca Global Management (Citigroup). Prior to that, she returned to Alger in 2001 as Senior Health Care Analyst and Portfolio Manager. Before returning to Alger, she was a portfolio manager and principal at Morgan Stanley. Her prior experience includes working as a health care analyst at Alger, and analyst and corporate finance roles at JP Morgan. Teresa earned her B.A. from Oberlin College and her M.B.A. from Columbia University.


Daniel C. Chung

Manager

Start Date

Oct 01, 2005

Tenure

12.01

Tenure Rank

13.1%

Daniel C. Chung, CFA is Chief Executive Officer, Chief Investment Officer and Portfolio Manager of several Alger strategies. Dan joined Alger in 1994 and has 19 years of investment experience. He was named Chief Investment Officer in September 2001, President in 2003 and CEO in 2006. Dan graduated from Stanford University with B.A. and B.S. degrees, with Distinction and Phi Beta Kappa, in 1984. He earned his J.D. magna cum laude from Harvard Law School in 1987, where he was an editor of the Harvard Law Review. After law school, he served as law clerk for the Honorable Justice Anthony M. Kennedy, United States Supreme Court. He joined Simpson Thacher & Bartlett LLP in New York City in 1989 and earned an L.L.M. from New York University. Dan is a CFA charterholder and a member of the CFA Institute. Throughout his tenure at Alger, Dan has made numerous TV appearances, including CNBC’s “The Wall Street Journal with Maria Bartiromo” and Bloomberg’s “Street Fighters.” Dan has also been featured and quoted frequently in Barron’s, Financial Advisor, Forbes, Fortune, Investment News, Smart Money, USA Today and the Wall Street Journal.


Tenure Analysis

Category Low

0.3

Category High

20.1

Category Average

9.06

Category Mode

0.7